Ascendis pharma a/s

Major-Pharmaceuticals

ASND


Tuborg Boulevard 12
Hellerup , 2900

Executive/
Director

Price

  • Last Close
  • $ 135.56
    $ +2.57 1.93 %
    Jun 27, 2024
  • 52-Week High/Low
  • $159.4 - $86.1
  • YTD
  • 7.6%

  • Trading Volume
  • 3,740
  • Market Cap Full
  • $ 7.7B
  • Shares Outstanding
  • 57.2M
    Dec 31, 2022
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - 1.3% 38.3% 63.3% 87.9% -5% -22.6% -12.8% -12.2% 20%
Q2 1.9% -28.5% -0.9% 10.8% -3.1% 4% 2.1% -20.8% -16.8% -3.7%
Q3 0.1% 51.5% 30.6% 6.1% -19.9% 8% 21.4% 11.1% 4.9% -
Q4 3.5% 0.7% 7.9% -10.1% 46.3% 7.9% -15.7% 18.3% 38.2% -
J F M A M J J A S O N D
2024 3.2% 13.7% 2.3% -3.2% - - - - - - - -
2023 1.6% -10.5% -3.5% -34.8% 24.3% 2.6% 1% 8.7% -4.5% -4.6% 12.5% 25.4%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%10%98%56%120%21%-19%-9%3%8%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.07 0.90 0.83 1.31 1.41 -1.46 -1.41 -2.48 -2.13
Q2 0.70 0.60 1.04 0.66 1.40 -2.17 -3.01 -1.55 -2.36
Q3 0.34 0.80 1.22 0.94 0.59 -2.7 -1.73 -3.05 -3.14
Q4 0.54 0.55 1.08 0.87 - -3.13 -2.13 -3.87 -
A 1.7 2.9 4.2 3.8 3.4 -9.46 -8.3 -11 -7.63

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022
Mar - - - - -
Jun - - - - -
Sep - - - - -
Dec 42.1 48 53.8 56.9 57.2

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 0.1 - - - -
Fixed Asset Turnover 0.3 - - 0.2 0.5
Total Asset Turnover 0.1 - - - -
Leverage
Debt Ratio 0.5 - - - -
Debt – Equity Ratio 1.8 - - - -
Interest Coverage -26.9 6.6 -3.7 25.4 6.3
Equity multiplier 0.6 0.3 0.3 0.1 0.1